Sushil Kumar Kabra
- Infectious Diseases top 2%
- Tuberculosis Research and Epidemiology 12
- HIV/AIDS drug development and treatment 11
-
- Tracheal and airway disorders 31
- Cystic Fibrosis Research Advances 28
- Neonatal Respiratory Health Research 18
- Epidemiology top 5%
- Pneumocystis jirovecii pneumonia detection and treatment 14
- Pneumonia and Respiratory Infections 12
-
- Asthma and respiratory diseases 14
- Co-authors
- Rakesh LodhaShobha BroorRandeep GuleriaMadhulika KabraJhuma SankarLalit DarKana Ram JatYogesh Jain
- Cited by
- Infectious DiseasesPulmonary and Respiratory MedicineCritical Care and Intensive Care Medicine
- Journals
- The Lancet (1 paper)SHILAP Revista de lepidopterología (2 papers)PLoS ONE (2 papers)
- Partner nations
- IndiaUnited StatesNorway
In The Last Decade
Sushil Kumar Kabra
163 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 127
- Infectious Diseases 663
- Pulmonary and Respiratory Medicine 705
- Critical Care and Intensive Care Medicine 96
- Public Health, Environmental and Occupational Health 472
- Epidemiology 549
Countries citing papers authored by Sushil Kumar Kabra
This map shows the geographic impact of Sushil Kumar Kabra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sushil Kumar Kabra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sushil Kumar Kabra more than expected).
Fields of papers citing papers by Sushil Kumar Kabra
This network shows the impact of papers produced by Sushil Kumar Kabra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sushil Kumar Kabra. The network helps show where Sushil Kumar Kabra may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sushil Kumar Kabra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 4 | |
| 13 | Clinical Profile of Children With Cystic Fibrosis Surviving Through Adolescence and Beyond. | 2022 | 1 |
| 14 | 2021 | 5 | |
| 15 | 2020 | 8 | |
| 16 | 2020 | 24 | |
| 17 | 2019 | 27 | |
| 18 | 2019 | 14 | |
| 19 | Calcinosis in juvenile dermatomyositis mimicking cold abscess. | 2016 | 2 |
| 20 | Can we identify acute severe viral lower respiratory tract infection clinically? | 2004 | 10 |
About Sushil Kumar Kabra
Sushil Kumar Kabra is a scholar working on Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine and Infectious Diseases, having authored 180 papers that have together received 2.3k indexed citations. Recurring topics across this work include Tracheal and airway disorders (31 papers), Cystic Fibrosis Research Advances (28 papers), Neonatal Respiratory Health Research (18 papers), Pneumocystis jirovecii pneumonia detection and treatment (14 papers), Asthma and respiratory diseases (14 papers), Tuberculosis Research and Epidemiology (12 papers), Pneumonia and Respiratory Infections (12 papers) and HIV/AIDS drug development and treatment (11 papers). The work is most often cited by research in Infectious Diseases (663 citations), Pulmonary and Respiratory Medicine (705 citations) and Critical Care and Intensive Care Medicine (96 citations). Sushil Kumar Kabra has collaborated with scholars based in India, United States and Norway. Frequent co-authors include Rakesh Lodha, Shobha Broor, Randeep Guleria, Madhulika Kabra, Jhuma Sankar, Lalit Dar, Kana Ram Jat, Yogesh Jain, Preeti Bharaj and Kavita Diddi. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.